206 related articles for article (PubMed ID: 18836294)
1. PTEN signaling pathways in glioblastoma.
Koul D
Cancer Biol Ther; 2008 Sep; 7(9):1321-5. PubMed ID: 18836294
[TBL] [Abstract][Full Text] [Related]
2. Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.
Li Y; Li B; Li W; Wang Y; Akgül S; Treisman DM; Heist KA; Pierce BR; Hoff B; Ho CY; Ferguson DO; Rehemtulla A; Zheng S; Ross BD; Li JZ; Zhu Y
Nat Commun; 2020 Jul; 11(1):3669. PubMed ID: 32699356
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genetic alterations in samples of malignant glioma patients.
Milinkovic V; Bankovic J; Rakic M; Stankovic T; Skender-Gazibara M; Ruzdijic S; Tanic N
PLoS One; 2013; 8(12):e82108. PubMed ID: 24358143
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype.
Nuechterlein N; Shelbourn A; Szulzewsky F; Arora S; Casad M; Pattwell S; Merino-Galan L; Sulman E; Arowa S; Alvinez N; Jung M; Brown D; Tang K; Jackson S; Stoica S; Chittaboina P; Banasavadi-Siddegowda YK; Wirsching HG; Stella N; Shapiro L; Paddison P; Patel AP; Gilbert MR; Abdullaev Z; Aldape K; Pratt D; Holland EC; Cimino PJ
Genes Dev; 2024 Apr; 38(5-6):273-288. PubMed ID: 38589034
[TBL] [Abstract][Full Text] [Related]
5. Determination of PDK1, SLC2A1, EGFR, PTEN, CD276 Gene Expression Levels and IDH1 Gene R132H Polymorphism in Brain Tumor Tissues.
Korkmaz S; Soylemez E; Soylemez Z; Solak M
Turk Neurosurg; 2023; 33(6):1086-1092. PubMed ID: 37528722
[TBL] [Abstract][Full Text] [Related]
6. Drosophila melanogaster as a model system for human brain cancers.
Read RD
Glia; 2011 Sep; 59(9):1364-76. PubMed ID: 21538561
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamic simulation and functional analysis of pathogenic PTEN mutations in glioblastoma.
Cetintas VB; Duzgun Z; Akalin T; Ozgiray E; Dogan E; Yildirim Z; Akinturk N; Biceroglu H; Ertan Y; Kosova B
J Biomol Struct Dyn; 2023; 41(21):11471-11483. PubMed ID: 36591942
[TBL] [Abstract][Full Text] [Related]
8. The Effect of
Stewart CE; Guerra-García ME; Luo L; Williams NT; Ma Y; Regal JA; Ghosh D; Sansone P; Oldham M; Deland K; Becher OJ; Kirsch DG; Reitman ZJ
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139666
[TBL] [Abstract][Full Text] [Related]
9. From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress.
Dewdney B; Jenkins MR; Best SA; Freytag S; Prasad K; Holst J; Endersby R; Johns TG
Signal Transduct Target Ther; 2023 Oct; 8(1):400. PubMed ID: 37857607
[TBL] [Abstract][Full Text] [Related]
10. Pre-clinical tumor models of primary brain tumors: Challenges and opportunities.
Akter F; Simon B; de Boer NL; Redjal N; Wakimoto H; Shah K
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188458. PubMed ID: 33148506
[TBL] [Abstract][Full Text] [Related]
11. Does the role of non-coding RNA FAM131B-AS2 in glioblastoma go beyond the ATR pathway? A correspondence.
Jalloh M; Osifala O; Kankam SB; Fakorede O
Neurosurg Rev; 2024 Apr; 47(1):192. PubMed ID: 38662138
[No Abstract] [Full Text] [Related]
12. Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment.
Delgado-Martín B; Medina MÁ
Adv Sci (Weinh); 2020 May; 7(9):1902971. PubMed ID: 32382477
[TBL] [Abstract][Full Text] [Related]
13. Emerging Therapies for Glioblastoma.
Rios SA; Oyervides S; Uribe D; Reyes AM; Fanniel V; Vazquez J; Keniry M
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672566
[TBL] [Abstract][Full Text] [Related]
14. New Cellular Dimensions on Glioblastoma Progression.
Portela M; Casas-Tintó S
Neurosci Insights; 2020; 15():2633105520923076. PubMed ID: 32548582
[TBL] [Abstract][Full Text] [Related]
15. Current available therapies and future directions in the treatment of malignant gliomas.
Desjardins A; Reardon DA; Vredenburgh JJ
Biologics; 2009; 3():15-25. PubMed ID: 19707392
[TBL] [Abstract][Full Text] [Related]
16. Mutations of PTEN gene in gliomas correlate to tumor differentiation and short-term survival rate.
Yang Y; Shao N; Luo G; Li L; Zheng L; Nilsson-Ehle P; Xu N
Anticancer Res; 2010 Mar; 30(3):981-5. PubMed ID: 20393024
[TBL] [Abstract][Full Text] [Related]
17. PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.
Benitez JA; Ma J; D'Antonio M; Boyer A; Camargo MF; Zanca C; Kelly S; Khodadadi-Jamayran A; Jameson NM; Andersen M; Miletic H; Saberi S; Frazer KA; Cavenee WK; Furnari FB
Nat Commun; 2017 May; 8():15223. PubMed ID: 28497778
[TBL] [Abstract][Full Text] [Related]
18. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.
Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA
Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540
[TBL] [Abstract][Full Text] [Related]
19. Targeting the AKT pathway in glioblastoma.
McDowell KA; Riggins GJ; Gallia GL
Curr Pharm Des; 2011; 17(23):2411-20. PubMed ID: 21827416
[TBL] [Abstract][Full Text] [Related]
20. The somatic genomic landscape of glioblastoma.
Brennan CW; Verhaak RG; McKenna A; Campos B; Noushmehr H; Salama SR; Zheng S; Chakravarty D; Sanborn JZ; Berman SH; Beroukhim R; Bernard B; Wu CJ; Genovese G; Shmulevich I; Barnholtz-Sloan J; Zou L; Vegesna R; Shukla SA; Ciriello G; Yung WK; Zhang W; Sougnez C; Mikkelsen T; Aldape K; Bigner DD; Van Meir EG; Prados M; Sloan A; Black KL; Eschbacher J; Finocchiaro G; Friedman W; Andrews DW; Guha A; Iacocca M; O'Neill BP; Foltz G; Myers J; Weisenberger DJ; Penny R; Kucherlapati R; Perou CM; Hayes DN; Gibbs R; Marra M; Mills GB; Lander E; Spellman P; Wilson R; Sander C; Weinstein J; Meyerson M; Gabriel S; Laird PW; Haussler D; Getz G; Chin L;
Cell; 2013 Oct; 155(2):462-77. PubMed ID: 24120142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
